LONDON (Reuters) – AstraZeneca is no longer pursuing U.S. approval of its COVID-19 vaccine, Chief Executive Pascal Soriot said in a media call on Thursday.
Demand for vaccines in the country is declining and the market is well served by the mRNA shots, he said.
(Reporting by Natalie Grover in London; Editing by Jan Harvey)
